A Genetic Test Could Help Predict the Right Antidepressant For You
Depression is a complicated condition, and so are the people it affects. It’s often difficult — and can take months or even years — to find the right drugs to treat the heterogeneous mood disorder. But for decades, doctors have been treating depression essentially by prescribing a drug and hoping for the best. They rely on asking people about their family history of mental illness and fold in as much information as they can about symptoms. Since 2010, however, there has been a genetic test that can help doctors learn how a person’s genetic makeup can also affect their response to various antidepress...
Source: TIME: Health - May 7, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Brain Depression healthy time Source Type: news

Soterix touts transcranial stim depression trial results
Soterix Medical today released results from trials of its direct current stimulation-limited total energy technology designed to treat depression, touting that the device was found to be safe and effective with improvements in depression-rating metrics lasting for a month after treatment. The tDCS-LTE system is designed to deliver energy to the dorsolateral prefrontal cortex region of the brain which is implicated in depression control, the New York-based company said. In the first trial, the company reported that its tDCS-LTE system was effective and safe as an add-on intervention for patients with type I or II bipolar di...
Source: Mass Device - April 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Neurological Neuromodulation/Neurostimulation Soterix Medical Source Type: news

Study: PET imaging agent could help predict depression drug ’ s efficacy
Image courtesy of Mala Ananth Researchers have identified a positron emission tomography imaging agent that could identify the patients that are more likely to benefit from a drug designed to treat major depressive disorder, according to a study published this month in The Journal of Nuclear Medicine. The C-DASB tracer targets a protein, 5-HTT, found in the part of a person’s brain that is responsible for emotional processing, called the amygdala. Escitalopram, a selective serotonin reuptake inhibitor, is indicated for people with depression, but it doesn’t work for all patients. Scanning a person’s ...
Source: Mass Device - April 6, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Imaging Neurological Pharmaceuticals Research & Development National Institutes of Health (NIH) Source Type: news

Lexapro vs. Cymbalta
Title: Lexapro vs. CymbaltaCategory: MedicationsCreated: 2/26/2018 12:00:00 AMLast Editorial Review: 2/26/2018 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - February 26, 2018 Category: Psychiatry Source Type: news

Lexapro vs. Paxil
Title: Lexapro vs. PaxilCategory: MedicationsCreated: 2/26/2018 12:00:00 AMLast Editorial Review: 2/26/2018 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - February 26, 2018 Category: Psychiatry Source Type: news

21 Reviewed Antidepressants Top Placebo for Major Depression
Agomelatine, amitriptyline, escitalopram are among most effective agents in head - to - head trials (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - February 22, 2018 Category: Psychiatry Tags: Family Medicine, Gynecology, Internal Medicine, Pharmacy, Psychiatry, Journal, Source Type: news

These Antidepressants Are Most Effective, Study Says
Millions of people take antidepressants for depression. But there’s long been debate over just how effective the medications actually are. On Wednesday, a large new study provides evidence that antidepressants are more effective than placebo at treating acute depression in adults. The study, published in the journal The Lancet, looked at the published data from 522 randomized controlled trials testing 21 different types of antidepressants. The study authors also reached out to pharmaceutical companies and study authors for additional unpublished study data. All told, the data collection included 116,477 men and women...
Source: TIME: Health - February 21, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized healthytime Mental Health/Psychology Source Type: news

Lexapro vs. Xanax
Title: Lexapro vs. XanaxCategory: MedicationsCreated: 2/21/2018 12:00:00 AMLast Editorial Review: 2/21/2018 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - February 21, 2018 Category: Psychiatry Source Type: news

Lexapro vs. Ativan
Title: Lexapro vs. AtivanCategory: MedicationsCreated: 2/21/2018 12:00:00 AMLast Editorial Review: 2/21/2018 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - February 21, 2018 Category: Psychiatry Source Type: news

Genotyping May Boost Antidepressant Treatment Success Genotyping May Boost Antidepressant Treatment Success
Impairments in the gene that encodes the enzyme responsible for metabolizing the antidepressant escitalopram may be responsible for treatment failure.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 19, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Genetic analysis can improve depression therapy
(Karolinska Institutet) The failure of SSRI antidepressants can be a result of genetic variations in patients. Variations within the gene that encodes the CYP2C19 enzyme results in extreme differences in the levels of escitalopram achieved in patients, according to a new study from Karolinska Institutet in Sweden and Diakonhjemmet Hospital in Norway published in The American Journal of Psychiatry. Prescribing the dose of escitalopram based on a patient's specific genetic constitution would greatly improve therapeutic outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 12, 2018 Category: International Medicine & Public Health Source Type: news

Celexa vs. Lexapro
Title: Celexa vs. LexaproCategory: MedicationsCreated: 12/18/2017 12:00:00 AMLast Editorial Review: 12/18/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 18, 2017 Category: Drugs & Pharmacology Source Type: news

Zoloft vs. Lexapro
Title: Zoloft vs. LexaproCategory: MedicationsCreated: 11/2/2017 12:00:00 AMLast Editorial Review: 11/2/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - November 2, 2017 Category: Drugs & Pharmacology Source Type: news

Lexapro vs. Wellbutrin: Differences between Side Effects and Uses
Title: Lexapro vs. Wellbutrin: Differences between Side Effects and UsesCategory: MedicationsCreated: 11/2/2017 12:00:00 AMLast Editorial Review: 11/2/2017 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - November 2, 2017 Category: Psychiatry Source Type: news

Lexapro vs. Effexor
Title: Lexapro vs. EffexorCategory: MedicationsCreated: 10/30/2017 12:00:00 AMLast Editorial Review: 10/30/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 30, 2017 Category: Drugs & Pharmacology Source Type: news

Secondary prevention of chronic PTSD by early and short-term administration of escitalopram: a prospective randomized, placebo-controlled, double-blind trial - Zohar J, Fostick L, Juven-Wetzler A, Kaplan Z, Shalev H, Schreiber G, Miroshnik N, Shalev AY, Stein DJ, Seedat S, Suliman S, Klein E.
OBJECTIVE: Prospective studies have not identified a viable pharmacologic strategy for secondary prevention of posttraumatic stress disorder (PTSD). The authors examined whether preventive intervention via early and short-term administration of a selective... (Source: SafetyLit)
Source: SafetyLit - July 22, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Brain Stimulation No Better Than Escitalopram for Depression
Patients receiving transcranial direct - current stimulation may experience more side effects (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - June 29, 2017 Category: Psychiatry Tags: Family Medicine, Nursing, Pharmacy, Psychiatry, Journal, Source Type: news

Not Just for Attention: Stop Teen Suicide
The subject of depression and suicide, especially in the case of children and teens, is a tremendous concern. Unfortunately, many cases go missed not necessarily because those surrounding these young people don’t care or pay enough attention to them, but more because they aren’t aware of what to look out for. I am a suicide survivor. I also grew up with a suicidal mother and witnessed a peer successfully commit suicide, ironically, when I was in the emergency room beside her being treated for the same thing. I was saved, while her family still mourns for her. These experiences, including the fact that my twelve...
Source: Psych Central - March 29, 2017 Category: Psychiatry Authors: Chynna Laird Tags: Antidepressants Children and Teens Depression Medications Personal Stories Self-Esteem Stress Suicide Therapists Spill Treatment Anxiety Coping Skills Depression Mood Depressive Episode Major Depressive Disorder Monoamine Oxi Source Type: news

The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: a secondary analysis - Bausch P, Fangmeier T, Zobel I, Schoepf D, Drost S, Schnell K, Walter H, Berger M, Normann C, Schramm E.
Childhood maltreatment (CM) has been indicated as a predictor of a differential response to antidepressant treatment with psychotherapy compared to medication. In this secondary analysis, we investigated whether the presence of CM results in a differential... (Source: SafetyLit)
Source: SafetyLit - March 24, 2017 Category: Global & Universal Tags: Age: Adolescents Source Type: news

Lexapro (Escitalopram Oxalate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 20, 2017 Category: Drugs & Pharmacology Source Type: news

The 6 Medications You Should Never Take When Driving
It’s a given that safe driving needs concentration, alertness and an ability to react in a coordinated and timely fashion. But what may not occur to you is that the medications you’re taking can seriously impact all of these things. And it’s not just prescription medications, but over-the-counter products as well. “While laws differ from state to state, you can be charged with a DUI if caught driving hazardously while taking prescription or OTC meds, even if your doctor wrote you that prescription,” adds C. Michael White, Pharm.D., FCP, FCCP, Professor and Head of the Department of Pharmacy Pr...
Source: Healthy Living - The Huffington Post - October 4, 2016 Category: Consumer Health News Source Type: news

Lexapro (escitalopram)
Title: Lexapro (escitalopram)Category: MedicationsCreated: 3/16/2003 12:00:00 AMLast Editorial Review: 8/15/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 15, 2016 Category: Drugs & Pharmacology Source Type: news

Fentanyl can cause serotonin syndrome
3.5 out of 5 stars Serotonin Syndrome Induced by Fentanyl in a Child: Case Report. Robles LA. Clin Neuropharmacol 2015 Sept-Oct;38:206-8. Abstract When many clinicians think of serotonin syndrome (SS), they consider the usual suspects: Selective Serotonin Uptake Inhibitors (SSRIs) Citalopram Fluoxetine Sertraline Escitalopram Paroxetine Serotonin-Norepinephrine Reuptake Inhibitors Venlafaxine Duloxetine Antidepressants Trazodone Buspirone Clomipramine Aside from these common culprits, there are other commonly used drugs whose clear association with serotonin syndrome is less-often realized: Fentanyl ...
Source: The Poison Review - July 8, 2016 Category: Toxicology Authors: Leon Gussow Tags: Medical fentanyl opioid serotonin syndrome Source Type: news

MOOD-HF supports lack of antidepressant efficacy in HF patients
Escitalopram influences neither depressive symptoms nor medical outcomes when compared with placebo in patients with heart failure and depression, show the MOOD-HF findings. (Source: MedWire News)
Source: MedWire News - June 28, 2016 Category: Consumer Health News Tags: Heart failure Source Type: news

Antidepressant Found Ineffective in Patients with Heart Failure (FREE)
By Joe Elia Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Escitalopram doesn't benefit depressed patients with heart failure, a JAMA study concludes.In Germany, researchers studied 372 patients … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 28, 2016 Category: Primary Care Source Type: news

Outcomes Similar for Escitalopram, Placebo in Depression + CHFOutcomes Similar for Escitalopram, Placebo in Depression + CHF
Although escitalopram was well tolerated, there were no differences between treatments "on the elevated mortality risk known to be associated with this comorbidity," note the MOOD-HF investigators. Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2016 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Escitalopram falls short in patients with heart failure and depression
Using escitalopram for patients with chronic heart failure and depression for more than 18 months neither significantly reduces mortality or hospitalization, nor improves depression, a study... (Source: Family Practice News)
Source: Family Practice News - June 28, 2016 Category: Primary Care Source Type: news

Antidepressant does not reduce hospitalization, death for HF patients with depression
Investigators have examined whether 24 months of treatment with the antidepressant escitalopram would improve mortality, illness, and mood in patients with chronic heart failure and depression. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 28, 2016 Category: Science Source Type: news

Antidepressant No Help to Heart Failure Patients: Study
TUESDAY, June 28, 2016 -- The antidepressant Lexapro may not help heart failure patients suffering from depression, German researchers report. "Depression in heart failure may not be the same depression patients without heart failure get and who... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 28, 2016 Category: Journals (General) Source Type: news

Depression blood test could lead to personalised treatments
Conclusion This study shows how a new blood test in development can help identify people with depression who are most and least likely to benefit from antidepressants. While promising, the test is far from perfect. For example, it missed 39-43% of non-responders, meaning these people would continue to receive standard antidepressant treatment that is unlikely to work for them. A large proportion of patients (22-38%) also fell into the "intermediate" group who were neither responders nor non-responders, so the test wasn't too useful here. This means there is a significant proportion of people with...
Source: NHS News Feed - June 7, 2016 Category: Consumer Health News Tags: Mental health Medication Source Type: news

My Super Fun Depression
This week, I celebrated twenty amazing years married to my best friend. I have two terrific kids, whose lives I wish I had. I have an excellent job on a global hit sitcom that regularly puts me within touching distance of John Stamos' hair. I have tons of friends, even more Facebook friends, nearly 20,000 Twitter followers and I blog on The Huffington Post. By any available metric, I have a good life. And not a day goes by that I don't struggle with depression. You're probably thinking, "Wait, I've seen you crack wise at work or breakdance at a bar mitzvah." Or crack wise at a bar mitzvah or breakdance at wor...
Source: Healthy Living - The Huffington Post - June 2, 2016 Category: Consumer Health News Source Type: news

Lexapro side effects: Is breast tenderness common?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - May 26, 2016 Category: Consumer Health News Source Type: news

Antidepressants and pregnancy: More research needed
Follow me at @Drmoniquetello For many women, pregnancy and the arrival of a new baby is a joyous time — but not for every woman. Recently, postpartum depression — extreme feelings of sadness and anxiety following the birth of a child — has come out from the shadows. But what about depression during pregnancy? It’s more common than you think: as many as 14% to 23% of pregnant women will experience symptoms of depression. It’s of sufficient public health concern that the U.S. Preventive Services Task Force recommends screening all pregnant women and new moms for depression. However, treatin...
Source: New Harvard Health Information - May 19, 2016 Category: Consumer Health News Authors: Monique Tello, MD, MPH Tags: Anxiety and Depression Behavioral Health Drugs and Supplements Family Planning and Pregnancy Source Type: news

More than sad: Depression affects your ability to think
When you think of clinical depression, you probably think of feeling sad and down for long periods of time; losing your energy and your interest in things you used to enjoy; sleeping too much or too little, or eating too much or too little. But besides these, depression can actually change your ability to think. It can impair your attention and memory, as well as your information processing and decision-making skills. It can also lower your cognitive flexibility (the ability to adapt your goals and strategies to changing situations) and executive functioning (the ability to take all the steps to get something done). For pe...
Source: New Harvard Health Information - May 6, 2016 Category: Consumer Health News Authors: James Cartreine, PhD Tags: Anxiety and Depression Behavioral Health Brain and cognitive health Mental Health Source Type: news

escitalopram, Lexapro
Title: escitalopram, LexaproCategory: MedicationsCreated: 3/16/2003 12:00:00 AMLast Editorial Review: 3/28/2016 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - March 28, 2016 Category: Psychiatry Source Type: news

Escitalopram reversed the traumatic stress-induced depressed and anxiety-like symptoms but not the deficits of fear memory - Lin CC, Tung CS, Liu YP.
RATIONALE: Posttraumatic stress disorder (PTSD) is a trauma-induced mental disorder characterised by fear extinction dysfunction in which fear circuit monoamines are possibly associated. PTSD often coexists with depressive/anxiety symptoms, and selective s... (Source: SafetyLit)
Source: SafetyLit - January 13, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Take Antidepressants? You May Be Staving Off Dementia
When you take an SSRI or mood stabilizer, you encounter plenty of people who say they, too, think they could benefit from something like that but they never would because we don't yet know what the end results could be. What if, in old age, they ended up growing a third arm because of their decades of Prozac? (Okay, no one's ever said that to me, but there are so many ignorant people running around telling those who take such medications they are not sober that I wouldn't put it past them. Ahem. Different topic.) Point being: As someone who's taken various medications of this ilk over the years, I've wrestled with the noti...
Source: Healthy Living - The Huffington Post - December 15, 2015 Category: Consumer Health News Source Type: news

Antidepressant may help prevent memory loss, dementia
Stephen FellerMAYWOOD, Ill., Dec. 1 (UPI) -- Researchers found treating depression patients with Lexapro caused the levels of two neurotoxic compounds connected to dementia to drop significantly. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 1, 2015 Category: Consumer Health News Source Type: news

Vasomotor Symptoms Relieved by Escitalopram, E2, VenlafaxineVasomotor Symptoms Relieved by Escitalopram, E2, Venlafaxine
Menopausal women with moderate vasomotor symptoms may find relief from escitalopram, low-dose dose oral 17-beta-estradiol, or venlafaxine, according to a pooled analysis. Medscape Medical News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - July 15, 2015 Category: OBGYN Tags: Ob/Gyn & Women ' s Health News Source Type: news

New Study Sheds Light On The Link Between Antidepressants And Birth Defects
A new study from the Centers for Disease Control and Prevention finds that pregnant women who take certain drugs that are part of a class of antidepressants known as SSRIs (selective serotonin reuptake inhibitors) are at slightly increased risk for having a baby with birth defects.  While this sounds frightening, the absolute risk for birth defects is still very low, cautioned study authors. For instance, women who took Paxil (paroxetine) would increase their risk for giving birth to a baby with anencephaly (a serious and often fatal brain and skull defect) from two per 10,000 to seven per 10,000. For a certain heart ...
Source: Science - The Huffington Post - July 10, 2015 Category: Science Source Type: news

Study links Prozac, Paxil use with birth defects
(Reuters) - A sweeping government study of thousands of women has found links between the older antidepressants Prozac and Paxil and birth defects, but has cleared other popular treatments in the class, including Celexa, Lexapro and Pfizer's Zoloft, which is the subject of a major lawsuit over birth defect claims. (Source: Reuters: Health)
Source: Reuters: Health - July 10, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Does escitalopram reduce neurotoxicity in major depression? - Halaris A, Myint AM, Savant V, Meresh E, Lim E, Guillemin G, Hoppensteadt D, Fareed J, Sinacore J.
This study examined whether treatment with the SSRI, escitalopram (ESC), could suppress inflammation and favorably shift metabolites of th... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - July 4, 2015 Category: Global & Universal Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news

Is It Bedtime for Benzos?
“Bernard also laughed; after two grams of soma the joke seemed, for some reason, good. Laughed and then, almost immediately, dropped off to sleep.” — Aldous Huxley, Brave New World It’s been a tough few years for benzodiazepines, the pharmaceutical industry’s top-selling family of prescription drugs. Tough in every way, that is, except sales: Xanax remains the world’s most popular pill, and U.S. prescriptions for it and other benzos grow by 12 percent every year. It’s their reputation, long enjoyed, as harmless and effective medicines that’s taking a flurry of hits — so...
Source: Science - The Huffington Post - June 25, 2015 Category: Science Source Type: news

ED sedation with droperidol is relatively safe and effective
This study has shown that droperidol is relatively safe and effective for the management of violent and aggressive patients in the ED and that there was no increased risk of QT prolongation and torsades de points according to a large cohort of cases.” The “Editor’s Capsule Summary” that accompanies the article is even more emphatic*: How this is relevant to clinical practice Droperidol is safe even with the high doses used in this study. The authors note that the study does not rule out that droperidol may be associated with rare cases of torsades. But the agitated, delirious ED patient may be a dan...
Source: The Poison Review - May 20, 2015 Category: Toxicology Authors: Leon Tags: Best of TPR Medical black box warning droperidol FDA food and drug administration QT prolongation torsades de pointes Source Type: news

Escitalopram in the Prevention of PTSDEscitalopram in the Prevention of PTSD
SSRIs are effective first-line pharmacotherapy for acute and chronic PTSD. Might they also be useful for PTSD prevention? BMC Psychiatry (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 30, 2015 Category: Consumer Health News Tags: Psychiatry Journal Article Source Type: news

MOOD-HF: SSRI No Better Than Placebo in Depressed CHF PatientsMOOD-HF: SSRI No Better Than Placebo in Depressed CHF Patients
A new study makes the case for not using escitalopram in CHF patients who are depressed, as there were no differences with placebo in hospitalizations, deaths, or even depression scores. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 25, 2015 Category: Cardiology Tags: Cardiology News Source Type: news

Medication and Anxiety
Medication can be an effective approach for managing various types of anxiety such as panic, hyperarousal, and constant worry. However, contrary to popular belief and subtle messages from pharmaceutical companies, medication is far from a cure. In fact, when it comes to “cures” for most psychiatric conditions, the data tends to support psychotherapy. For example, post-traumatic stress disorder (PTSD) responds very well to psychotherapy, whereas the positive effects of medication are somewhat limited. The same is true for panic disorder. Although certain types of medication are very good at relieving panic sympt...
Source: Psych Central - March 11, 2015 Category: Psychiatry Authors: Bret Moore, PsyD Tags: Anti-anxiety Antidepressants Benzodiazepines Disorders General Medications Panic Disorder anti-anxiety medications Drug Dependency Fear Hyperarousal Sedatives Selective Serotonin Reuptake Inhibitor snri Ssri Substance Abuse Source Type: news

Why The Science Behind Anti-Depressants May Be Completely 'Backwards'
Anti-depressants are the most commonly-prescribed medication in the U.S., with one in 10 Americans currently taking pills like Zoloft and Lexapro to treat depression. But these pharmaceuticals are only fully effective roughly 30 percent of the time, and often come with troublesome side effects. In a controversial new paper published in the journal Neuroscience & Biobehavioral Reviews, psychologist Paul Andrews of McMaster University in Ontario argues that this failure of medication may be based in a misunderstanding of the underlying chemistry related to depression. Andrews surveyed 50 years' worth of research supp...
Source: Science - The Huffington Post - February 28, 2015 Category: Science Source Type: news

Why The Science Behind Anti-Depressants May Be Completely 'Backwards'
Anti-depressants are the most commonly-prescribed medication in the U.S., with one in 10 Americans currently taking pills like Zoloft and Lexapro to treat depression. But these pharmaceuticals are only fully effective roughly 30 percent of the time, and often come with troublesome side effects. In a controversial new paper published in the journal Neuroscience & Biobehavioral Reviews, psychologist Paul Andrews of McMaster University in Ontario argues that this failure of medication may be based in a misunderstanding of the underlying chemistry related to depression. Andrews surveyed 50 years' worth of research supp...
Source: Healthy Living - The Huffington Post - February 28, 2015 Category: Consumer Health News Source Type: news

The Science Behind Anti-Depressants May Be Completely 'Backwards'
Anti-depressants are the most commonly-prescribed medication in the U.S., with one in 10 Americans currently taking pills like Zoloft and Lexapro to treat depression. But these pharmaceuticals are only effective less than 30 percent of the time, and often come with troublesome side effects. In a controversial new paper published in the journal Neuroscience & Biobehavioral Reviews, psychologist Paul Andrews of McMaster University in Ontario argues that this failure of medication may be based in a misunderstanding of the underlying chemistry related to depression. Andrews surveyed 50 years' worth of research supporti...
Source: Healthy Living - The Huffington Post - February 28, 2015 Category: Consumer Health News Source Type: news